Venkatesh K. Nadar
Expertise in
11
conditions

Dr. Venkatesh K. Nadar

Cardiology
875 Poplar Church Road, Suite 300, 
Camp Hill, PA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
11
conditions
875 Poplar Church Road, Suite 300, 
Camp Hill, PA 

Overview

Venkatesh K. Nadar, MD, specializes in cardiology. He is affiliated with UPMC Community Osteopathic, UPMC West Shore and UPMC Pinnacle Harrisburg. Dr. Nadar completed his fellowship and residency at Marshall University School of Medicine and medical degree at Madras University.

Dr. Nadar is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Angina, Heart Attack, X-Linked Cardiac Valvular Dysplasia, Cardiac Diverticulum, and Heart Bypass Surgery.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 12 clinical trials. Dr. Nadar is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in PA

Fellowships

Marshall University School of Medicine

Hospital Affiliations

Milton S Hershey Medical Center
Gettysburg Hospital
Penn State Health Holy Spirit Medical Center
Upmc Pinnacle Hospitals

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Capital Area Cardiovascular Associates
875 Poplar Church Road, Suite 300, Camp Hill, PA 17011

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia
A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia
Enrollment Status: Completed
Publish Date: December 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
Enrollment Status: Active_not_recruiting
Publish Date: April 04, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Randomized & Controlled Noninferiority Trial to Evaluate Safety & Clinical Efficacy of SurVeil™ Drug-Coated Balloon (DCB) iN Treatment of Subjects With Stenotic Lesions of Femoropopliteal Artery Compared to Medtronic IN.PACT® Admiral® DCB
Enrollment Status: Completed
Publish Date: March 25, 2025
Intervention Type: Device
Study Phase: Not Applicable
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)
Enrollment Status: Completed
Publish Date: May 22, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo and Once-Weekly Dulaglutide in Participants With Type 2 Diabetes Mellitus
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo and Once-Weekly Dulaglutide in Participants With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drugs: LY3502970, Dulaglutide
Study Phase: Phase 2
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drug: LY3502970
Study Phase: Phase 2
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3, Randomized, Open-Label Trial Comparing Efficacy and Safety of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Semaglutide
Study Phase: Phase 3
View 9 Less Clinical Trials

1 Total Publications

Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Journal: Vascular medicine (London, England)
Published: May 12, 2016
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Pinnacle Health Cardiovascular Institute Inc.

1000 N Front St, 
Lemoyne, PA 
 (2.4 miles away)
717-731-0101
Languages Spoken:
English
See accepted insurances

Hemal Gada is a Cardiologist practicing medicine in Lemoyne, Pennsylvania. Dr. Gada is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Mitral Valve Regurgitation, Atrial Fibrillation, Pacemaker Implantation, and Transcatheter Aortic Valve Replacement (TAVR).

Expertise in
33
conditions
Expertise in
33
conditions
Referral may be required
Before you request

The Milton S. Hershey Medical Center

500 University Dr, 
Hershey, PA 
 (13.5 miles away)
717-531-8407
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gerald Naccarelli is a Cardiologist practicing medicine in Hershey, Pennsylvania. Dr. Naccarelli is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Arrhythmias, Ectopic Heartbeat, Familial Ventricular Tachycardia, and Cardiac Ablation. Dr. Naccarelli is currently accepting new patients.

Expertise in
9
conditions
Dr. Amit N. Vora
Cardiology
Expertise in
9
conditions
Dr. Amit N. Vora
Cardiology
Referral may be required

Pinnacle Health Cardiovascular Institute Inc.

1000 N Front St, 
Lemoyne, PA 
 (2.4 miles away)
717-731-0101
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Amit Vora is a Cardiologist practicing medicine in Lemoyne, Pennsylvania. Dr. Vora is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Atrial Fibrillation, Heart Attack, Pacemaker Implantation, and Transcatheter Aortic Valve Replacement (TAVR).

Frequently Asked Questions about Dr. Venkatesh K. Nadar

How do I make an appointment with Dr. Venkatesh K. Nadar?

You can book an appointment with Dr. Venkatesh K. Nadar by calling their office at 223-895-3730. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Venkatesh K. Nadar a top-rated expert for Angina?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Venkatesh K. Nadar is classified as an Advanced expert for Angina, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Venkatesh K. Nadar specialize in?

While Dr. Venkatesh K. Nadar is a Cardiology, they have specific expertise in Angina, Heart Attack, and X-Linked Cardiac Valvular Dysplasia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Venkatesh K. Nadar participate in research or clinical trials?

Yes. Dr. Venkatesh K. Nadar has published 1 articles and abstracts on conditions like Angina. You can view a list of Dr. Venkatesh K. Nadar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Venkatesh K. Nadar accept my insurance?

Dr. Venkatesh K. Nadar accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 223-895-3730 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nadar's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 50 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile